IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 123 filers reported holding IMMUNOCORE HLDGS PLC in Q2 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,942,304 | -13.4% | 576,923 | 0.0% | 35.70% | +29.7% |
| Q2 2023 | $34,592,303 | +21.3% | 576,923 | 0.0% | 27.53% | +9.3% |
| Q1 2023 | $28,523,073 | -13.4% | 576,923 | 0.0% | 25.19% | -0.7% |
| Q4 2022 | $32,924,996 | +21.5% | 576,923 | 0.0% | 25.37% | +18.4% |
| Q3 2022 | $27,100,000 | +26.0% | 576,923 | 0.0% | 21.42% | +29.6% |
| Q2 2022 | $21,500,000 | +25.0% | 576,923 | 0.0% | 16.53% | +78.7% |
| Q1 2022 | $17,200,000 | -69.2% | 576,923 | 0.0% | 9.25% | -45.4% |
| Q4 2021 | $55,800,000 | +160.7% | 576,923 | 0.0% | 16.93% | +170.2% |
| Q3 2021 | $21,400,000 | -7.0% | 576,923 | 0.0% | 6.26% | +77.3% |
| Q2 2021 | $23,000,000 | -6.4% | 576,923 | 0.0% | 3.53% | -12.1% |
| Q1 2021 | $24,560,000 | – | 576,923 | – | 4.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $24,560,000 | 4.02% |
| Rock Springs Capital Management LP | 2,292,285 | $97,583,000 | 2.13% |
| RTW INVESTMENTS, LP | 1,245,532 | $50,142,000 | 0.78% |
| Avidity Partners Management LP | 550,000 | $23,414,000 | 0.65% |
| Samsara BioCapital, LLC | 80,000 | $3,406,000 | 0.63% |
| Bain Capital Public Equity Management II, LLC | 300,871 | $12,808,000 | 0.53% |
| GENERAL ATLANTIC, L.P. | 950,000 | $40,442,000 | 0.47% |
| Baker Brothers Advisors | 2,520,730 | $107,307,000 | 0.46% |
| Perceptive Advisors | 400,000 | $17,028,000 | 0.22% |
| Pinz Capital Management, LP | 18,700 | $796,000 | 0.21% |